Signup Crypto ETF Stocks News

SFC Shuts Down Fraudulent Platforms Misusing Bennet Investment's Identity

HONG KONG, June 10, 2025 ( GLOBE NEWSWIRE ) -- Bennet Investment today announced a significant regulatory breakthrough as the Securities and Futures Commission ( SFC ) has successfully dismantled multiple fraudulent platforms that were unlawfully using its brand and those of other reputable ...

Source: www.benzinga.com
June 10, 2025 | 10:55:50
Category: General

Report on transactions of executives and related parties in ROCKWOOL A/S shares

Company announcementfor ROCKWOOL A/SRelease no. 36 - 2025to Nasdaq Copenhagen ...

Source: www.globenewswire.com
June 10, 2025 | 10:56:00
Category: News

Nvidia's Grace Hopper Platform Powers Europe's Fastest AI Supercomputer - NVIDIA ( NASDAQ:NVDA )

Nvidia announced building Europe's most advanced AI supercomputer, JUPITER. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy right here. Nvidia Corp NVDA on Tuesday announced that the JUPITER supercomputer, powered by the Nvidia Grace Hopper platform, is ...

Source: www.benzinga.com
June 10, 2025 | 10:57:01
Category: News

Brunswick Exploration Once More Outlines a New, Major Dyke at Mirage - Brunswick Exploation ( OTC:BRWXF )

MONTREAL, June 10, 2025 ( GLOBE NEWSWIRE ) -- Brunswick Exploration Inc. BRW OTCQB: BRWXF. "BRW" or the "Company" ) , ( TSX-V: BRW, OTCQB:BRWXF. "BRW" or the "Company" ) , "BRW" or the "Company" ) is pleased to report a further six drill results from the Winter 2025 program at its Mirage Project.

Source: www.benzinga.com
June 10, 2025 | 11:00:00
Category: General

SHAWN RYAN TO HOST NEW PRESTIGE AUDIO DOCUSERIES FROM IRONCLAD, 'TARGET INTELLIGENCE: PSYOP'

Podcasting superstar Shawn Ryan is joining up with IRONCLAD for a new prestige docuseries, TARGET INTELLIGENCE: PSYOP. VIRGINIA BEACH, Va., June 10, 2025 /PRNewswire/ -- Podcasting star and special operations veteran Shawn Ryan has signed a deal with media company IRONCLAD to host a new prestige ...

Source: www.benzinga.com
June 10, 2025 | 11:00:00
Category: General

Monte Rosa Therapeutics Announces FDA Clearance of IND Application for MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases - Monte Rosa Therapeutics ( NASDAQ:GLUE )

MRT-8102, a highly selective NEK7-directed molecular glue degrader ( MGD ) developed to treat inflammatory conditions linked to NLRP3, IL-1β, and IL-6 dysregulation, expands Monte Rosa's clinical I&I portfolio

Source: www.benzinga.com
June 10, 2025 | 11:00:00
Category: General

Kaleris Acquires Locus Software

ATLANTA, June 10, 2025 ( GLOBE NEWSWIRE ) -- Kaleris, a global provider of leading supply chain optimization technology, today announced the acquisition of Locus Software, an operations management system for carriers.

Source: www.benzinga.com
June 10, 2025 | 11:00:00
Category: Mergers

InStride Redefines Workforce Development Through Strategic Expansion

LOS ANGELES, June 10, 2025 ( GLOBE NEWSWIRE ) -- InStride, a leading provider of strategic education and skilling solutions, today announced continued growth, accelerated by its new and transformative approach to workforce development.

Source: www.benzinga.com
June 10, 2025 | 11:00:00
Category: General

Manitoba Harvest and Whole Foods Market Collaborate to Launch New Protein-Packed, Hemp+ Superfood Smoothie Boosters - Tilray Brands ( NASDAQ:TLRY )

Global Superseed Leader, Manitoba Harvest, Expands their Wellness Lineup with Smoothie Blends for Enhanced Nutrition Plus Energy, Mood and Immune Support NEW YORK and WINNIPEG, Manitoba, June 10, 2025 ( GLOBE NEWSWIRE ) -- Manitoba Harvest, the global leader in hemp foods and a wellness business ...

Source: www.benzinga.com
June 10, 2025 | 11:00:00
Category: General

Axsome Therapeutics Announces Availability of SYMBRAVO® ( meloxicam and rizatriptan ) for the Acute Treatment of Migraine with or without Aura in Adults - Axsome Therapeutics ( NASDAQ:AXSM )

SYMBRAVO represents a novel multi-mechanistic approach to treating migraine that addresses multiple pathways underlying a migraine attack SYMBRAVO On My Side offers comprehensive patient support services including access and prescription drug support

Source: www.benzinga.com
June 10, 2025 | 11:00:00
Category: General

© Natavest 2025 - 2026